rs727503832
Positions:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BP6BS2
The NM_001127222.2(CACNA1A):c.6494G>A(p.Arg2165His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,386,104 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00016 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
CACNA1A
NM_001127222.2 missense
NM_001127222.2 missense
Scores
4
13
2
Clinical Significance
Conservation
PhyloP100: 1.80
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CACNA1A. . Gene score misZ 5.7845 (greater than the threshold 3.09). Trascript score misZ 3.9354 (greater than threshold 3.09). GenCC has associacion of gene with benign paroxysmal torticollis of infancy, developmental and epileptic encephalopathy, 42, undetermined early-onset epileptic encephalopathy, episodic ataxia type 2, familial or sporadic hemiplegic migraine, spinocerebellar ataxia type 6, Lennox-Gastaut syndrome, migraine, familial hemiplegic, 1.
BP6
Variant 19-13209344-C-T is Benign according to our data. Variant chr19-13209344-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 166765.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=3}.
BS2
High AC in GnomAd4 at 24 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1A | NM_001127222.2 | c.6494G>A | p.Arg2165His | missense_variant | 45/47 | ENST00000360228.11 | NP_001120694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.6494G>A | p.Arg2165His | missense_variant | 45/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6512G>A | p.Arg2171His | missense_variant | 46/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.6500G>A | p.Arg2167His | missense_variant | 45/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.6497G>A | p.Arg2166His | missense_variant | 45/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.6497G>A | p.Arg2166His | missense_variant | 45/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.6461G>A | p.Arg2154His | missense_variant | 44/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.6356G>A | p.Arg2119His | missense_variant | 44/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.6497G>A | p.Arg2166His | missense_variant | 45/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.6512G>A | p.Arg2171His | missense_variant | 46/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.6503G>A | p.Arg2168His | missense_variant | 46/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.6500G>A | p.Arg2167His | missense_variant | 45/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.6497G>A | p.Arg2166His | missense_variant | 45/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.6497G>A | p.Arg2166His | missense_variant | 45/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.6461G>A | p.Arg2154His | missense_variant | 44/46 | 5 | ENSP00000489777.1 | |||
CACNA1A | ENST00000636768.1 | n.*760G>A | non_coding_transcript_exon_variant | 9/10 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000636768.1 | n.*760G>A | 3_prime_UTR_variant | 9/10 | 5 | ENSP00000490190.2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152172Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
24
AN:
152172
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000161 AC: 7AN: 43604Hom.: 0 AF XY: 0.000230 AC XY: 5AN XY: 21782
GnomAD3 exomes
AF:
AC:
7
AN:
43604
Hom.:
AF XY:
AC XY:
5
AN XY:
21782
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000152 AC: 187AN: 1233932Hom.: 0 Cov.: 32 AF XY: 0.000160 AC XY: 95AN XY: 594898
GnomAD4 exome
AF:
AC:
187
AN:
1233932
Hom.:
Cov.:
32
AF XY:
AC XY:
95
AN XY:
594898
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000158 AC: 24AN: 152172Hom.: 1 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74328
GnomAD4 genome
AF:
AC:
24
AN:
152172
Hom.:
Cov.:
33
AF XY:
AC XY:
16
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:3Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | CACNA1A: PP2, PP3 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 27, 2014 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 24, 2021 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 18, 2020 | - - |
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 18, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.;.;.;.;T;.;.;T;.;.;.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;.;.;.;M;.;.;.;.;.;.;.;.;.;.;.;.;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
T;T;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.
Vest4
MVP
MPC
0.35
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at